Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411441 | SCV000486941 | likely pathogenic | Biotinidase deficiency | 2016-09-09 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000411441 | SCV004211436 | likely pathogenic | Biotinidase deficiency | 2023-08-11 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV004999364 | SCV005625376 | likely pathogenic | not provided | 2024-07-17 | criteria provided, single submitter | clinical testing | The BTD c.1307_1308del (p.Glu436Alafs*8) variant alters the translational reading frame of the BTD mRNA and is predicted to cause the premature termination of BTD protein synthesis. This variant has not been reported in individuals with BTD-related conditions in the published literature. This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as likely pathogenic. |